Skip to content
10-Q

Quarterly Report

MABVAX THERAPEUTICS HOLDINGS, INC.

0001654954-18-011104

← back to feed
Filed
Oct 15, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Oct 11, 2018 9.25M sh
Capex Q2 2018 · Jun 30, 2018 $0
Capex Q2 2018 · Jun 30, 2017 $4.14K
Long Term Debt Q2 2018 · Jun 30, 2018 $2.78M
Cash And Equivalents Q2 2018 · Jun 30, 2018 $594.41K
Cash And Equivalents Q2 2018 · Dec 31, 2017 $885.71K
Cash And Equivalents Q2 2018 · Jun 30, 2017 $1.85M
Cash And Equivalents Q2 2018 · Dec 31, 2016 $3.98M
Stockholders Equity Q2 2018 · Jun 30, 2018 −$566.74K
Stockholders Equity Q2 2018 · Dec 31, 2017 $1.13M
Current Liabilities Q2 2018 · Jun 30, 2018 $7.73M
Current Liabilities Q2 2018 · Dec 31, 2017 $5.81M
Total Liabilities Q2 2018 · Jun 30, 2018 $8.84M
Total Liabilities Q2 2018 · Dec 31, 2017 $7.66M
Current Assets Q2 2018 · Jun 30, 2018 $768.31K
Current Assets Q2 2018 · Dec 31, 2017 $1.21M
Total Assets Q2 2018 · Jun 30, 2018 $8.27M
Total Assets Q2 2018 · Dec 31, 2017 $8.79M
Sga Expense Q2 2018 · Jun 30, 2018 $2.08M
Sga Expense Q2 2018 · Jun 30, 2018 $3.89M
Sga Expense Q2 2018 · Jun 30, 2017 $3.41M
Sga Expense Q2 2018 · Jun 30, 2017 $5.68M
Rd Expense Q2 2018 · Jun 30, 2018 $1.09M
Rd Expense Q2 2018 · Jun 30, 2018 $2.72M
Rd Expense Q2 2018 · Jun 30, 2017 $2.33M
Rd Expense Q2 2018 · Jun 30, 2017 $5.15M
Net Income Q2 2018 · Jun 30, 2018 −$2.63M
Net Income Q2 2018 · Jun 30, 2018 −$6.25M
Net Income Q2 2018 · Jun 30, 2017 −$5.99M
Net Income Q2 2018 · Jun 30, 2017 −$11.34M
Operating Income Q2 2018 · Jun 30, 2018 −$2.47M
Operating Income Q2 2018 · Jun 30, 2018 −$5.9M
Operating Income Q2 2018 · Jun 30, 2017 −$5.74M
Operating Income Q2 2018 · Jun 30, 2017 −$10.83M
Revenue Q2 2018 · Jun 30, 2018 $700K
Revenue Q2 2018 · Jun 30, 2018 $700K
Revenue Q2 2018 · Jun 30, 2017 $0
Revenue Q2 2018 · Jun 30, 2017 $0